Drug Trial Radar · NCT07327840
Phase 2 Study of Kylo-11 in ASCVD Patients With Elevated Lp(a)
Last checked: Nov 19, 2026Latest source record: Oct 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
204
Planned (sponsor's estimate)
Start
Oct 29, 2025
Primary completion
Sep 30, 2026
Study completion Aug 31, 2028
Sponsor
- Lead sponsor
- Kylonova (Xiamen) Biopharma co., LTD.Industry
- Sponsor type
- Industry
- First posted
- Jan 8, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a phase 2, double-blind, randomized, placebo-controlled, multi-center, dose-finding study to evaluate the efficacy and safety of Kylo-11 administered subcutaneously compared to placebo in participants with ASCVD and elevated Lp(a).
Conditions
- Lipoprotein Disorder
Interventions
Kylo-11 or matched placeboDrug
Administered subcutaneously
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent change from baseline in time-averaged Lp(a) over Weeks 8~26Time frame: Baseline, Weeks 8~26
Locations
48 sites in 2 countries. Site status is shown where the registry gives one.
Alliance Clinical - Los Angeles
Los Angeles, California
FOMAT - Clinicas mi Salud
Oxnard, California
Alliance Clinical - San Diego
San Diego, California
FOMAT - Comprehensive Cardiovascular Care-Santa Maria California
Santa Maria, California
Excel Medical Trials - Flourish Research
Boca Raton, Florida
Clinical Research of West Florida (CRWF) - Clearwater
Clearwater, Florida
Arrow Clinical Trials LLC
Daytona Beach, Florida
Family Research and Healthcare Center Inc.
Doral, Florida
Family Research Centers - Hialeah
Hialeah, Florida
Jacksonville Center for Clinical Research
Jacksonville, Florida
Universal Axon Clinical Research
Miami, Florida
Clinical Research of West Florida (CRWF) - Tampa
Tampa, Florida
Flourish Orlando - Flourish Research
Winter Park, Florida
Emory Healthcare-Emory Heart & Vascular Center - Executive Park
Atlanta, Georgia
Centricity Research - Columbus
Columbus, Georgia
Care Access-Lake Charles, LA
Lake Charles, Louisiana
Alliance Clinical Las Vegas Excel Clinical Research
Las Vegas, Nevada
Centricity Research d/b/a Lucas Research, Inc.
Morehead City, North Carolina
The First Affiliated Hospital of Baotou Medical College
Baotou, China
Beijing Anzhen Hospital
Beijing, China
Beijing Chao-Yang Hospital, Capital Medical University
Beijing, China
The First People's Hospital of Changde
Changde, China
Chongqing University Three Gorges Hospital
Chongqing, China
The First Affiliated Hospital of Dali University
Dali, China
Daqingshi People's Hospital
Daqing, China
The Second Affiliated Hospital of Guangzhou Medical University
Guangzhou, China
The Fourth Affiliated Hospital of Harbin Medical University
Harbin, China
The First Affiliated Hospital of University of South China
Hengyang, China
The First Hospital of Jilin University
Jilin City, China
Central Hospital Affiliated to Shandong First Medical University
Jinan, China
Lishui Central Hospital
Lishui, China
Luoyang Third People's Hospital
Luoyang, China
The First Affiliated Hospital of Henan University of Science and Technology
Luoyang, China
Nanyang Medical College First Affiliated Hospital
Nanyang, China
The First Affiliated Hospital of Ningbo University
Ningbo, China
Hainan Third People's Hospital
Sanya, China
Shanghai Putuo District Central Hospital
Shanghai, China
Zhongshan Hospital Fudan University, Qingpu Branch
Shanghai, China
The First Hospital of Hebei Medical University
Shijiazhuang, China
TEDA International Cardiovascular Hospital
Tianjin, China
Showing 40 of 48 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.